Skip to main content

Table 9 Access by naturopaths to private and public resources and reimbursementsc

From: Characteristics of global naturopathic education, regulation, and practice frameworks: results from an international survey

 

Regulation Type

Total (n=65)

No Regulation (n=28)b

Title protection (n=18)b

Defined Practice (n=27)b

Other (n=7)b

Access to private health insurance

N (%)

N (%)

N (%)

N (%)

N (%)

 Full/Limited Access

41 (63.1)

14 (50.0)

16 (88.9)

20 (74.0)

7 (100.0)

 Not Allowed/Not Applicable

23 (35.4)

13 (46.4)

1 (5.5)

6 (22.2)

0 (0.0)

 Unsure

3 (4.6)

1 (3.5)

1 (5.5)

1 (3.7)

0 (0.0)

Access to government funded public health

 Full/Limited Access

9 (13.8)a

2 (7.1)a

6 (33.3)a

8 (29.6)a

0 (0.0)

 Not Allowed/Not Applicable

55 (84.6)

25 (89.2)a

11 (61.1)a

18 (66.6)a

7 (100.0)

 Unsure

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

Access to medical integration (hospital privileges)

 Full/Limited Access

14 (21.5)a

4 (14.2)a

10 (55.5)a

11 (40.7)a

1 (14.2)

 Not Allowed/Not Applicable

49 (75.4)

23 (82.1)a

7 (38.8)a

14 (51.8)a

6 (85.7)

 Unsure

1 (1.5)

0 (0.0)

0 (0.0)

1 (3.7)

0 (0.0)

Method of payment/cost reimbursement for naturopathic services

 Direct payment by patient (no reimbursement by third-party)

  Consultation Costs

43 (66.2)

13 (46.4)

12 (66.6)

20 (74.0)

4 (57.1)

  Naturopathic Product Prescriptions

42 (64.6)

13 (46.4)

13 (72.2)

20 (74.0)

5 (71.4)

  In-Office treatments

38 (58.5)

11 (39.2)

13 (72.2)

20 (74.0)

4 (57.1)

 Government funded / public health reimbursement

  Consultation Costs

6 (9.2)

0 (0.0)

6 (33.3)

6 (22.2)

0 (0.0)

  Naturopathic Product Prescriptions

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

  In-Office treatments

7 (10.8)

1 (3.5)

6 (33.3)

5 (18.5)

1 (14.2)

 Private health insurance reimbursement

  Consultation Costs

36 (55.4)

13 (46.4)

13 (72.2)

19 (70.3)

4 (57.1)

  Naturopathic Product Prescriptions

14 (21.5)

5 (17.8)

4 (22.2)

4 (14.8)

1 (14.2)

  In-Office treatments

36 (55.4)

11 (39.2)

14 (77.7)

18 (66.6)

4 (57.1)

 Other third-party funder reimbursement (e.g. Veteran’s affairs, Employer-funded workplace injury insurance)

  Consultation Costs

10 (15.4)

2 (7.1)

4 (22.2)

6 (22.2)

1 (14.2)

  Naturopathic Product Prescriptions

1 (1.5)

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

  In-Office treatments

7 (10.8)

1 (3.5)

3 (16.6)

4 (14.8)

1 (14.2)

 Not applicable

  Consultation Costs

10 (15.4)

9 (32.1)

0 (0.0)

1 (3.7)

0 (0.0)

  Naturopathic Product Prescriptions

10 (15.4)

8 (28.5)

0 (0.0)

1 (3.7)

0 (0.0)

  In-Office treatments

9 (13.8)

7 (25.0)

0 (0.0)

1 (3.7)

0 (0.0)

Factors that impact patient cost reimbursement of naturopathic services

 Practitioner must have malpractice insurance

21 (32.3)

11 (39.2)

5 (27.7)

11 (40.7)

3 (42.8)

 Practitioner must have registered title/number from regulatory body

30 (46.2)

9 (32.1)

11 (61.1)

18 (66.6)

4 (57.1)

 Patient characteristics (e.g. veterans, workplace, injury, elderly)

3 (4.6)

1 (3.5)

3 (16.6)

3 (11.1)

0 (0.0)

 Diagnosed disease/condition

13 (20.0)

2 (7.1)

8 (44.4)

9 (33.3)

2 (28.5)

 Level of practitioner education/qualification

19 (29.2)

10 (35.7)

7 (38.8)

9 (33.3)

2 (28.5)

 Referral from a medical practitioner

8 (12.3)

3 (10.7)

3 (16.6)

3 (11.1)

1 (14.2)

 Type of therapies /treatments provided by the practitioner

24 (36.9)

7 (25.0)

11 (61.1)

14 (51.8)

3 (42.8)

 Other

13 (20.0)

6 (21.4)

5 (27.7)

7 (25.9)

1 (14.2)

 Not applicable

19 (29.2)

12 (42.8)

1 (5.5)

3 (11.1)

1 (14.2)

  1. aAdjusted for missing data; b.Some respondents reported multiple regulation types.c Analysis excluded Belgium, Egypt, Hong Kong, State (USA) which did not indicate regulation type